BioTech Scout

Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.

back to Directory

Moderna Therapeutics

Moderna Therapeutics logo

Founded
2010
Patents
50
Publications
68

Technologies

Gene Therapy Startups

At Moderna, we are pioneering the development of a new class of drugs made of messenger RNA (mRNA). This novel drug platform builds on the discovery that modified mRNA can direct the body’s cellular machinery to produce nearly any protein of interest, from native proteins to antibodies and other entirely novel protein constructs that can have therapeutic activity inside and outside of cells.


Posts Mentioning This Company

11 Publicly Traded Biotechs Utilizing AI-based Research Platforms (+ 3 Upcoming Public Debuts)

  
According to our intelligence report, The State of Artificial Intelligence (AI) in the Biopharma Industry, more than 450 life sciences companies in the categories "startups" and "scaleups" are actively using machine learning and deep learning-based predictive and generative capabilities to augment their research strategies.  Some companies are incorporating AI tools …

Tech-First Companies Take the Lead in AI Drug Discovery

  
In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has announced the signing of agreements to acquire Cyclica and Valence, two companies with expertise in AI-enabled drug discovery. These acquisitions strengthen Recursion's position in computational chemistry, machine learning, and artificial intelligence, enhancing its technology-enabled drug discovery capabilities …

From Qubits to Cures: The Promise of Quantum Computing in Pharmaceutical Research and Development (a Realistic View)

  
In a recent announcement, Moderna and IBM unveiled their partnership aimed at utilizing cutting-edge technologies, such as artificial intelligence (AI) and quantum computing, to accelerate research in messenger RNA (mRNA) therapeutics and vaccines. This collaboration highlights the growing interest in the potential of quantum computing within the life sciences sector.

15 Biopharma Research Trends to Watch in 2022

  
Table of contents:    mRNA vaccines and RNA therapies  Epitranscriptomics Targeting RNA with small molecules Deep learning and big data in drug discovery Neoantigens Theranostics  Exosomes Synthetic Biology 3D Bioprinting Antibiotics “anti-trend” (and hope?) Nanotechnologies in Drug Delivery Gene Editing (CRISPR-Cas9) Aging research  Microbiome  Protein Degraders   Discoveries made in …

How Pharma Reacts To Wuhan Coronavirus Outbreak

  
UPDATE April 04. 2020. The number of confirmed cases of COVID19 approaches 1M globally. Since too many drug repurposing programs and vaccine development projects have been urgently initiated, we decided to summarize them in a separate post: A Running List Of COVID-19 Treatments And Vaccines In Development With this, we …